INDV Indivior Pharmaceuticals Inc
Stable Earnings Power
F 30.0 / 100 pillar composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

⚠ 2 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.

Grade overrides the 30.0 pillar composite — hard gates always win.

Profitability

Weight: 20%
A 87
  • 5yr Avg ROIC 38.2%
  • Operating Margin Trend +0.06 pp/yr

Capital Efficiency

Weight: 15%
B- 64
  • 5yr Avg ROE 7.6%
  • 5yr Share-Count CAGR -2.7%

Growth Quality

Weight: 15%
A 92
  • 5yr Revenue CAGR 13.9%
  • Revenue-Growth Years (5) 5/5

Cash Generation

Weight: 15%
C+ 57
  • 5yr FCF Margin -0.0%
  • 5yr FCF/NI Conversion 1.20x

Balance Sheet

Weight: 20%
A- 83
  • Net Debt / EBITDA 0.51x
  • Interest Coverage (EBIT/Int) 6.31x
  • Altman Z-Score 3.33

Stability

Weight: 15%
D+ 42
  • EPS Volatility (σ/μ) 0.78
  • Negative-Revenue Years (5) 0/5
  • Piotroski F-Score 4

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

5 of 5 gurus held; 3 added; 2 trimmed; 1 full exit.

Holders
5
Avg Δ position
+253.9%
New buys
0
Full exits
1
As of Q2 2026